ReviewCanadian family physician Medecin de famille canadien2025
Top studies of 2024 relevant to primary care: From the PEER team.
Review in Canadian family physician Medecin de famille canadien, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify and summarize the most impactful medical articles published in 2024 relevant to primary care. SELECTING THE EVIDENCE: Randomized controlled trials and meta-analyses relevant to primary care were identified by the PEER (Patients, Experience, Evidence, Research) team, a Canadian evidence-based medicine research group with a focus on primary care. The table of contents of major medical journals were reviewed as well as medical email alert services. The articles were ranked by the PEER team and selected studies were summarized. MAIN MESSAGE: Articles addressed various clinical areas in primary care. Topics included a behavioural strategy to reduce chronic benzodiazepine use for insomnia; the roles of β-blockers and colchicine after myocardial infarction; the effect of intensive blood pressure lowering on major cardiovascular outcomes; the effect of vitamin D on fracture prevention; walking for preventing recurrent back pain; testosterone for sexual dysfunction; methotrexate for osteoarthritis; dual antiplatelet use in patients with stable coronary artery disease and atrial fibrillation; and expanding indications for glucagon-like peptide-1 agonists. Four studies that evaluated the impact of screening and guideline-adherence strategies on patient outcomes were honourable mentions.
conclusionSeveral clinical trials and meta-analyses published in 2024 were relevant to primary care, particularly in the areas of insomnia, cardiology, and musculoskeletal disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.